Product Detail
Lubiprostone-d7
Lubiprostone Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
Lubiprostone
Storage
Keep in a tightly closed vial, store in freezer
Hazard Information
Refer MSDS for accurate information.
Lubiprostone-d7 Product Information
Lubiprostone-d7 is listed under Stable Isotopes. It is associated with Lubiprostone and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-O-06737.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Lubiprostone-d7
CAS No.
1217675-13-2
CAT No.
CS-O-06737
Molecular Formula
C20H25D7F2O5
Molecular Weight
397.51
Category
API Family
Storage Condition
Keep in a tightly closed vial, store in freezer
SMILES
O=C(O)CCCCCC[C@@H]1[C@@H](CCC(C(F)(F)CC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O)[C@H](O)CC1=O
IUPAC Name
7-((1R,2R,3R)-2-(4,4-difluoro-3-oxooctyl-6,6,7,7,8,8,8-d7)-3-hydroxy-5-oxocyclopentyl)heptanoic acid
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.
Description
Overview
" Labelled Lubiprostone is a bicyclic fatty acid metabolite analog of Prostaglandin E1. It activates specific chloride channels in the gastrointestinal tract to stimulate intestinal fluid secretion, increase gastrointestinal transit, and improve symptoms;Labeled Lubiprostone, intended for use as an internal standard for the quantification of Lubiprostone by GC- or LC-mass spectrometry."
Synonyms
7-((1R,2R,3R)-2-(4,4-difluoro-3-oxooctyl-6,6,7,7,8,8,8-d7)-3-hydroxy-5-oxocyclopentyl)heptanoic acid
Application Notes
" Labelled Lubiprostone is a bicyclic fatty acid metabolite analog of Prostaglandin E1. It activates specific chloride channels in the gastrointestinal tract to stimulate intestinal fluid secretion, increase gastrointestinal transit, and improve symptoms;Labeled Lubiprostone, intended for use as an internal standard for the quantification of Lubiprostone by GC- or LC-mass spectrometry."
References
"Farthing; M,; et al,: Drugs; 56; 11 (1998); Pare; P,; et al,: Am, J, Gastroenterol,; 96; 3130 (2001); Sloots; C,; et al,: Aliment, Pharmacol, Ther,; 16; 759 (2002); Coremans; G,; et al,: Digestion; 67; 82 (2003);"
